Skip to main content
SpringerLink
Log in

PET imaging in pediatric oncology

  • Minisymposium
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

High-quality PET imaging of pediatric patients is challenging and requires attention to issues commonly encountered in the practice of pediatric nuclear medicine, but uncommon to the imaging of adult patients. These include intravenous access, fasting, sedation, consent, and clearance of activity from the urinary tract. This paper discusses some technical differences involved in pediatric PET to enhance the quality of scans and assure the safety and comfort of pediatric patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1A, B
Fig. 2
Fig. 3
Fig. 4
Fig. 5A, B
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Tarantola G, Zito F, Gerundini P (2003) PET instrumentation and reconstruction algorithms in whole body applications. J Nucl Med 44:756–769

    PubMed  Google Scholar 

  2. Hamblen SM, Lowe VJ (2003) Clinical 18F-FDG oncology patient preparation techniques. J Nucl Med Technol 31: 3–7

    PubMed  Google Scholar 

  3. Shulkin BL, Wieland DM, Baro ME, et al (1996) PET hydroxyephedrine imaging of neuroblastoma. J Nucl Med 37:16–21

    CAS  PubMed  Google Scholar 

  4. American Academy of Pediatrics, Committee on Drugs. Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures (1992) Pediatrics. 89:1110–1115

  5. American Society of Anesthesiologists, Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists (2002) Anesthesiology 96:1004–1017

    PubMed  Google Scholar 

  6. Townsend DW, Beyer T (2002) A combined PET-CT scanner: the path to true image fusion. Br J Radiol 75[Suppl]:S24–30

  7. Dizendorf E, Hany TF, Buck A, et al (2003) Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies. J Nucl Med 44:732–738

    PubMed  Google Scholar 

  8. Shulkin BL, Mitchell DS, Ungar DR, et al (1995) Neoplasms in a pediatric population: 2-[F-18]-Fluoro-2-deoxy-d-glucose PET studies. Radiology 194:495–500

    CAS  PubMed  Google Scholar 

  9. Shulkin BL, Hutchinson RJ, Castle VP, et al (1996) Neuroblastoma: positron emission tomography with 2-[fluorine-18]fluoro-2-deoxy-d-glucose compared with metaiodobenzylguanidine scintigraphy. Radiology 199:743–750

    CAS  PubMed  Google Scholar 

  10. Jadvar H, Connolly LP, Shulkin BL, et al (2000) Positron emission tomography in pediatrics. Nucl Med Annu 2000:53–83

    Google Scholar 

Download references

Acknowledgements

The authors wish to thank Jill Rothley, CNMT, Andrew Weeden, CNMT, Paul Kison, CNMT, Edward McKenna, CNMT, Shana Huber, CNMT, Stan Wegryrn, CNMT, Lahti Lahti, CNMT, Lindsey Murray, CNMT, and Elizabeth Wynn, CNMT, for expertise in the preparation for and performing of PET scans in our pediatric patients. The authors thank Carol Kruise for assistance in preparation of the manuscript.

Author information

Authors and Affiliations

  1. Division of Nuclear Medicine, Department of Radiology, University of Michigan Medical Center, UH B1G 412 Box 0288, Ann Arbor, MI 48109, USA

    Barry L. Shulkin

Authors
  1. Barry L. Shulkin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barry L. Shulkin.

Additional information

This work was supported by NCI R01 CA54217 and M01-RR00042 from the Clinical Research Center of the University of Michigan

CME activity Please find the CME information and questions at the end of this issue

The author(s) have no financial interest, arrangement, or affiliation to disclose in the context of this CME activity. There is nothing to disclose regarding investigational or “off-label” use of medical devices or other products, or any pharmaceutical agents

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shulkin, B.L. PET imaging in pediatric oncology. Pediatr Radiol 34, 199–204 (2004). https://doi.org/10.1007/s00247-003-1112-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-003-1112-5

Keywords

Search

Navigation